Literature DB >> 27113566

Spatiotemporal Fractionation Schemes for Irradiating Large Cerebral Arteriovenous Malformations.

Jan Unkelbach1, Marc R Bussière2, Paul H Chapman3, Jay S Loeffler2, Helen A Shih2.   

Abstract

PURPOSE: To optimally exploit fractionation effects in the context of radiosurgery treatments of large cerebral arteriovenous malformations (AVMs). In current practice, fractionated treatments divide the dose evenly into several fractions, which generally leads to low obliteration rates. In this work, we investigate the potential benefit of delivering distinct dose distributions in different fractions. METHODS AND MATERIALS: Five patients with large cerebral AVMs were reviewed and replanned for intensity modulated arc therapy delivered with conventional photon beams. Treatment plans allowing for different dose distributions in all fractions were obtained by performing treatment plan optimization based on the cumulative biologically effective dose delivered at the end of treatment.
RESULTS: We show that distinct treatment plans can be designed for different fractions, such that high single-fraction doses are delivered to complementary parts of the AVM. All plans create a similar dose bath in the surrounding normal brain and thereby exploit the fractionation effect. This partial hypofractionation in the AVM along with fractionation in normal brain achieves a net improvement of the therapeutic ratio. We show that a biological dose reduction of approximately 10% in the healthy brain can be achieved compared with reference treatment schedules that deliver the same dose distribution in all fractions.
CONCLUSIONS: Boosting complementary parts of the target volume in different fractions may provide a therapeutic advantage in fractionated radiosurgery treatments of large cerebral AVMs. The strategy allows for a mean dose reduction in normal brain that may be valuable for a patient population with an otherwise normal life expectancy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27113566      PMCID: PMC4909567          DOI: 10.1016/j.ijrobp.2016.02.001

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  14 in total

1.  The rationale and technique of staged-volume arteriovenous malformation radiosurgery.

Authors:  B E Pollock; R W Kline; S L Stafford; R L Foote; P J Schomberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-10-01       Impact factor: 7.038

2.  Stereotactic radiosurgery for arteriovenous malformations, Part 1: management of Spetzler-Martin Grade I and II arteriovenous malformations.

Authors:  Hideyuki Kano; L Dade Lunsford; John C Flickinger; Huai-che Yang; Thomas J Flannery; Nasir R Awan; Ajay Niranjan; Josef Novotny; Douglas Kondziolka
Journal:  J Neurosurg       Date:  2011-11-11       Impact factor: 5.115

3.  Stereotactic radiosurgery for arteriovenous malformations, Part 6: multistaged volumetric management of large arteriovenous malformations.

Authors:  Hideyuki Kano; Douglas Kondziolka; John C Flickinger; Kyung-Jae Park; Phillip V Parry; Huai-che Yang; Sait Sirin; Ajay Niranjan; Josef Novotny; L Dade Lunsford
Journal:  J Neurosurg       Date:  2011-11-11       Impact factor: 5.115

4.  Bioeffect modeling and equieffective dose concepts in radiation oncology--terminology, quantities and units.

Authors:  Søren M Bentzen; Wolfgang Dörr; Reinhard Gahbauer; Roger W Howell; Michael C Joiner; Bleddyn Jones; Dan T L Jones; Albert J van der Kogel; André Wambersie; Gordon Whitmore
Journal:  Radiother Oncol       Date:  2012-11-15       Impact factor: 6.280

5.  Single-fraction proton beam stereotactic radiosurgery for cerebral arteriovenous malformations.

Authors:  Jona A Hattangadi-Gluth; Paul H Chapman; Daniel Kim; Andrzej Niemierko; Marc R Bussière; Alison Stringham; Juliane Daartz; Christopher Ogilvy; Jay S Loeffler; Helen A Shih
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-04-11       Impact factor: 7.038

6.  Radiosurgery for low-grade intracranial arteriovenous malformations.

Authors:  Dale Ding; Chun-Po Yen; Zhiyuan Xu; Robert M Starke; Jason P Sheehan
Journal:  J Neurosurg       Date:  2014-03-07       Impact factor: 5.115

7.  Volume-staged radiosurgery for large arteriovenous malformations: an evolving paradigm.

Authors:  Zachary A Seymour; Penny K Sneed; Nalin Gupta; Michael T Lawton; Annette M Molinaro; William Young; Christopher F Dowd; Van V Halbach; Randall T Higashida; Michael W McDermott
Journal:  J Neurosurg       Date:  2015-07-03       Impact factor: 5.115

8.  Simultaneous optimization of dose distributions and fractionation schemes in particle radiotherapy.

Authors:  Jan Unkelbach; Chuan Zeng; Martijn Engelsman
Journal:  Med Phys       Date:  2013-09       Impact factor: 4.071

9.  Fractionated, stereotactic proton beam treatment of cerebral arteriovenous malformations.

Authors:  H Silander; L Pellettieri; P Enblad; A Montelius; E Grusell; C Vallhagen-Dahlgren; U Isacsson; G Nyberg; U Moström; A Lilja; G Gál; E Blomquist
Journal:  Acta Neurol Scand       Date:  2004-02       Impact factor: 3.209

10.  Hypofractionated stereotactic radiotherapy for large or involving critical organs cerebral arteriovenous malformations.

Authors:  Sławomir Blamek; Dawid Larysz; Leszek Miszczyk; Adam Idasiak; Adam Rudnik; Rafał Tarnawski
Journal:  Radiol Oncol       Date:  2013-02-01       Impact factor: 2.991

View more
  2 in total

1.  Spatiotemporal fractionation schemes for liver stereotactic body radiotherapy.

Authors:  Jan Unkelbach; Dávid Papp; Melissa R Gaddy; Nicolaus Andratschke; Theodore Hong; Matthias Guckenberger
Journal:  Radiother Oncol       Date:  2017-09-23       Impact factor: 6.280

2.  Technical Note: A step-by-step guide to Temporally Feathered Radiation Therapy planning for head and neck cancer.

Authors:  Shireen Parsai; Richard L J Qiu; Peng Qi; Juan C L Alfonso; Jeremy Donaghue; Eric Murray; David Majkszak; Nicole Dorio; Clifton D Fuller; Kristy Brock; Shlomo Koyfman; Neil Woody; Nikhil Joshi; Jacob G Scott
Journal:  J Appl Clin Med Phys       Date:  2020-05-08       Impact factor: 2.243

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.